171 related articles for article (PubMed ID: 21157435)
1. Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice.
Li H; Tuyishime S; Wu TL; Giles-Davis W; Zhou D; Xiao W; High KA; Ertl HC
Mol Ther; 2011 Mar; 19(3):536-46. PubMed ID: 21157435
[TBL] [Abstract][Full Text] [Related]
2. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.
Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW
Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T cell recognition of epitopes within the capsid of adeno-associated virus 8-based gene transfer vectors depends on vectors' genome.
Wu TL; Li H; Faust SM; Chi E; Zhou S; Wright F; High KA; Ertl HC
Mol Ther; 2014 Jan; 22(1):42-51. PubMed ID: 24077034
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
[TBL] [Abstract][Full Text] [Related]
5. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets.
Wang L; Figueredo J; Calcedo R; Lin J; Wilson JM
Hum Gene Ther; 2007 Mar; 18(3):185-94. PubMed ID: 17324107
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes.
Hui DJ; Basner-Tschakarjan E; Chen Y; Davidson RJ; Buchlis G; Yazicioglu M; Pien GC; Finn JD; Haurigot V; Tai A; Scott DW; Cousens LP; Zhou S; De Groot AS; Mingozzi F
Mol Ther; 2013 Sep; 21(9):1727-37. PubMed ID: 23857231
[TBL] [Abstract][Full Text] [Related]
7. The Effect of CpG Sequences on Capsid-Specific CD8
Xiang Z; Kurupati RK; Li Y; Kuranda K; Zhou X; Mingozzi F; High KA; Ertl HCJ
Mol Ther; 2020 Mar; 28(3):771-783. PubMed ID: 31839483
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to cryptic epitopes during therapeutic gene transfer.
Li C; Goudy K; Hirsch M; Asokan A; Fan Y; Alexander J; Sun J; Monahan P; Seiber D; Sidney J; Sette A; Tisch R; Frelinger J; Samulski RJ
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10770-4. PubMed ID: 19541644
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction.
Finn JD; Hui D; Downey HD; Dunn D; Pien GC; Mingozzi F; Zhou S; High KA
Mol Ther; 2010 Jan; 18(1):135-42. PubMed ID: 19904235
[TBL] [Abstract][Full Text] [Related]
10. Identification of the murine AAVrh32.33 capsid-specific CD8+ T cell epitopes.
Mays LE; Wilson JM
J Gene Med; 2009 Dec; 11(12):1095-102. PubMed ID: 19777488
[TBL] [Abstract][Full Text] [Related]
11. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.
He Y; Weinberg MS; Hirsch M; Johnson MC; Tisch R; Samulski RJ; Li C
Hum Gene Ther; 2013 May; 24(5):545-53. PubMed ID: 23534873
[TBL] [Abstract][Full Text] [Related]
13. Identification of mouse AAV capsid-specific CD8+ T cell epitopes.
Sabatino DE; Mingozzi F; Hui DJ; Chen H; Colosi P; Ertl HC; High KA
Mol Ther; 2005 Dec; 12(6):1023-33. PubMed ID: 16263332
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
[TBL] [Abstract][Full Text] [Related]
15. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
16. Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors.
Pien GC; Basner-Tschakarjan E; Hui DJ; Mentlik AN; Finn JD; Hasbrouck NC; Zhou S; Murphy SL; Maus MV; Mingozzi F; Orange JS; High KA
J Clin Invest; 2009 Jun; 119(6):1688-95. PubMed ID: 19436115
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Mingozzi F; Maus MV; Hui DJ; Sabatino DE; Murphy SL; Rasko JE; Ragni MV; Manno CS; Sommer J; Jiang H; Pierce GF; Ertl HC; High KA
Nat Med; 2007 Apr; 13(4):419-22. PubMed ID: 17369837
[TBL] [Abstract][Full Text] [Related]
18. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
[TBL] [Abstract][Full Text] [Related]
19. The immunodominant CD8+ T cell epitope region of Theiler's virus in resistant C57BL/6 mice is critical for anti-viral immune responses, viral persistence, and binding to the host cells.
Myoung J; Hou W; Kang B; Lyman MA; Kang JA; Kim BS
Virology; 2007 Mar; 360(1):159-71. PubMed ID: 17095033
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.
Li C; Hirsch M; DiPrimio N; Asokan A; Goudy K; Tisch R; Samulski RJ
J Virol; 2009 Jul; 83(13):6817-24. PubMed ID: 19369348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
